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Abstract
Background: This study investigates the allosteric coupling that exists between the intra- and extracellular parts
of human β2-adrenergic receptor (β2-AR), in the presence of the intracellular loop 3 (ICL3), which is missing in all
crystallographic experiments and most of the simulation studies reported so far. Our recent 1 μs long MD run has
revealed a transition to the so-called very inactive state of the receptor, in which ICL3 packed under the G protein’s
binding cavity and completely blocked its accessibility to G protein. Simultaneously, an outward tilt of transmembrane
helix 5 (TM5) caused an expansion of the extracellular ligand-binding site. In the current study, we performed
independent runs with a total duration of 4 μs to further investigate the very inactive state with packed ICL3 and
the allosteric coupling event (three unrestrained runs and five runs with bond restraints at the ligand-binding site).
Results: In all three independent unrestrained runs (each 500 ns long), ICL3 preserved its initially packed/closed
conformation within the studied time frame, suggesting an inhibition of the receptor’s activity. Specific bond
restraints were later imposed between some key residues at the ligand-binding site, which have been experimentally
determined to interact with the ligand. Restraining the binding site region to an open state facilitated ICL3 closure,
whereas a relatively constrained/closed binding site hindered ICL3 packing. However, the reverse operation, i.e. opening
of the packed ICL3, could not be realized by restraining the binding site region to a closed state. Thus, any attempt
failed to free the ICL3 from its locked state due to the presence of persistent hydrogen bonds.
Conclusions: Overall, our simulations indicated that starting with very inactive states, the receptor stayed almost
irreversibly inhibited, which in turn decreased the overall mobility of the receptor. Bond restraints which represented
the geometric restrictions caused by ligands of various sizes when bound at the ligand-binding site, induced the
expected conformational changes in TM5, TM6 and consequently, ICL3. Still, once ICL3 was packed, the allosteric
coupling became ineffective due to strong hydrogen bonds connecting ICL3 to the core of the receptor.
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Background
Human β2-adrenergic receptor (β2-AR) is a member of
the G-protein coupled receptor (GPCR) superfamily
that is responsible in the eukaryotic signal transduction,
responding to hormones adrenaline and noradrenaline
to mainly induce the smooth muscle relaxation in the
lung tissue. As all members of GPCRs, β2-AR shares
the 7TM structural motif, which consists of seven
transmembrane-spanning alpha helices connected by
loop regions at the intra- and extracellular sides of the
membrane.
As the first hormone-activated GPCR structure to be
reported by X-ray crystallography [1, 2], the high reso-
lution structural information was obtained through the
elimination of the third intracellular loop (ICL3) re-
placed with the protein T4 lysozyme (T4L) and also the
C-terminal tail in order to increase both the proteolytic
stability and crystallizability. ICL3 links the cytoplasmic
ends of transmembrane helices V and VI (TM5 and
TM6) and has a functional role for both the recognition
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and the activation of G proteins [3, 4]. Unlike other
intracellular loop regions, ICL3 has a highly variable
length and sequence among the members of the GPCR
superfamily, even the closely related subtypes. It is be-
lieved that a GPCR’s selectivity to different G proteins
originated in the structural uniqueness of ICL3.
One experimental study conducted by West et al. [5]
investigated the ligand-dependent perturbation of the
conformational ensemble for β2-AR, which incorporated
the ICL3 region through hydrogen/deuterium exchange
(HDX) coupled with mass spectroscopy. HDX data sug-
gested ICL3’s role as a molecular switch, where antagon-
ist and inverse agonist binding shifted the equilibrium
toward inactive states, which is characterized by protec-
tion to exchange (i.e., stabilization) in the ICL3 loop and
flanking regions of TM helices V and VI. In contrast, bind-
ing of a full agonist shifted equilibrium toward higher ac-
cessibility and/or destabilization of ICL3 region. The lack
of mobility or the stabilization of ICL3 was also observed
in our previous work by Ozcan et al.[6], where the pres-
ence of ICL3 had a significant impact on the overall dy-
namics of the receptor, especially the arrangements of
some key residues at both the ligand-binding site and the
G-protein binding site. In that study, in addition to the
loop model where the missing ICL3 region was generated
in fully atomistic detail, a second model called clipped
model was created with the two open ends of TM5 and
TM6 covalently bonded to each other. During the 1 μs
long MD run, the loop model found a very inactive con-
formation towards 600 ns, when TM6 moved towards the
receptor’s core region with ICL3 packing underneath the
membrane and blocking the G-protein’s binding site. ICL3
preserved its closed conformation and consequently, the
receptor’s overall dynamics has decreased significantly
with only minor fluctuations for the remaining 400 ns,
and became similar to the clipped model’s dynamics,
which showed no major variations.
Early experimental peptide studies showed that the pep-
tides synthesized with the primary sequence 259–273 cor-
responding to ICL3 region of Gs-coupled β2-AR, selectively
bind with G proteins, stimulate their functional activity,
trigger signaling cascade in the absence of hormonal stimu-
lus, and decrease the regulatory effects of β2-AR agonists
[7–9]. Another peptide study revealed that the ICL3-de-
rived peptides can form helical structures and contain
clusters of positively charged residues exposed to one
helix side which is crucial for interacting with the nega-
tively charged receptor binding site of the Gαs subunit
(Shinagawa et al. [10], Okuda et al, [11]). The last result
is in good agreement with the simulation study by
Ozcan et al. [6] during which the unstructured loop
region generated through modeling techniques adopted
a few turns of helices before blocking the G-protein
binding cavity.
Yet, despite its functional significance, many experimen-
tal and simulation studies conducted so far have neglected
its presence [12–15]. The present work focuses on the
effect of the intracellular loop region ICL3 on the intrinsic
dynamics of the receptor. The intrinsic dynamics is the
key determinant of the receptor’s function, whereas the
tertiary structure encodes the dynamic behavior. Thus, it
is important to have a complete 3D structure of the recep-
tor in order to understand the system’s function to a
greater degree.
The study presented here adopted the same atomistic
model of the receptor that incorporates the ICL3 region
generated in our previous study [6]. First, we start by in-
vestigating the stability of the alternative inactive state of
the receptor, which was observed during the last half of
the 1 μs long MD simulation. The most distinguishing fea-
tures of the alternative state was the closure of ICL3
that completely blocked the G protein binding site at
the intracellular region, and the simultaneous enlarge-
ment of the ligand-binding site at the extracellular part.
Both regions of the receptor changed their conform-
ation almost simultaneously which suggested a strong
allosteric coupling. In two independent continuation
MD runs (500 ns long each), the receptor preserved its
stable ICL3 conformation as well as the extracellular
part of the receptor.
In addition to the presence of ICL3, the allosteric effect
was further investigated through specific bond restraints
between key residues at the ligand-binding site, which led
to an alternative closed state. Also, the probability of open-
to-closed or closed-to-open transition in ICL3 conform-
ation was revealed for the first time. Addition of restraints
mimics the presence/interaction of the ligand and possibly
accelarates the closure event. So, the conformational shift
that would take place in the presence of the ligand
would require much longer simulations, whereas the
restraints have provided an enhanced event sampling
by providing an exaggerated driving force or perturb-
ation at the binding site.
Even though the allosteric coupling that exists be-
tween the intracellular and the extracellular regions of
the receptor is a well-known feature of β2-AR and
many other GPCRs, the presence of ICL3, which dir-
ectly influences the overall dynamics of the receptor,
was not taken into consideration when the coupling be-
havior was investigated. Therefore, the present study
will be the first in providing this correlated motion that
exists between the extracellular ligand-binding site and
the intracellular G-protein binding site that incorpo-
rates the ICL3 region. Through imposing distance re-
straints between some key residues at the ligand-binding
site, we were able to trigger a series of conformational
changes in the transmembrane helices that led to the close
packing of ICL3.
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Methods
Protein-membrane system preparation
The system under study was adopted from Ozcan’s work
[6] where the initial conformation was the x-ray crystal-
lographic structure of human β2AR in complex with T4
lysozyme and the partial inverse agonist carazolol (PDB
id: 2RH1) at 2.4 Å resolution [2]. The anchor protein
T4L was covalently attached to two ends of helices 5
and 6 in order to facilitate crystallization. After removal
of T4L, the missing intracellular loop region ICL3 was
added between residues 230 and 262 after being mod-
eled as an unstructured loop of 32 residues long via
homology modeling tool, MODWEB [16]. Also, the
bound ligand at the ligand-binding site was removed
and the apo form of the receptor was used as an initial
conformation.
The receptor was then embedded in the double-layered
1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) phospho-
lipid cell membrane generated with VMD’s Plug-in tool
[17]. The receptor was positioned with an oblique angle of
8° between its main principal component along the mem-
brane and the z-axis [18]. After solvating the protein-lipid
system with VMD’s solvate module, Na+ and Cl- ions were
added to neutralize the total charge of the system, which is
necessary for Particle-Mesh Ewald summation method
used in electrostatic energy calculations [19]. The resulting
periodic box dimensions were (86x86x100) in Angstrom.
The total number of atoms in the system was 68.001, of
which 5.055 belong to protein, 20.770 to lipids, 42.135 to
water molecules, and 41 to ions.
The system’s equilibration consisted of several stages such
as melting of lipid tails, minimization and equilibration with
protein restrained, equilibration with protein released and
lastly the production runs [6]. Nanoscale Molecular Dy-
namics (NAMD) v2.8 software tool was used for all our
MD runs [20]. The force fields used were CHARMM27
[21, 22] for lipids, CHARMM22 [23, 24] for proteins and
TIP3P model for water in the system [25]. In this work, the
isothermal-isobaric (NPT) ensemble was employed using
Langevin dynamics in order to keep the temperature con-
stant with a Langevin damping coefficient (gamma) of 5/ps
for all non-hydrogen atoms. The pressure was kept con-
stant at 1 atm using a Nose-Hoover Langevin piston with
100 fs period and 50 ps damping timescale [26]. Long-
range electrostatic interactions were treated by particle
mesh Ewald (PME) method, with a grid point density of
over 1 Å. A cutoff of 12 Å was used for van der Waals and
short-range electrostatics interactions with a switching
function. Time step was set to 2 fs by using SHAKE algo-
rithm for bonds involving hydrogens [27] and the data was
recorded at every 200 ps. The number of time steps be-
tween each full electrostatics evaluation was set to 2. Short-
range non-bonded interactions were calculated at every
time step.
Independent MD runs with and without restraints
All MD runs are listed in Table 1. The first one is actually
from our previous study and will be used as reference here.
Two independent 500 ns runs named as “MD1μs_cont1”
and “MD1μs_cont2” were continuations of the first run.
They were based on the final snapshot of the original run
“MD1μs”, which corresponds to a very inactive state of the
receptor with a closed ICL3 that packed underneath the re-
ceptor [6]. No restraints were applied to the binding site in
these continuation runs. The goal here was to observe how
long ICL3 would preserve its closed state, which also indi-
cate its conformational stability.
In order to study the effect of restraints on the overall
dynamics of β2AR, especially of ICL3, additional bond en-
ergy terms were applied to seven pairs of key residues lo-
cated at the ligand-binding cavity that are known to be
critical in binding signaling molecules (See Table 2). All
extra bonded terms were harmonic potentials of the form
U(x) = k(x − xref)
2 where k is the spring constant and xref is
the restraint distance value. A total of five independent
MD runs named as rstr1 to rstr5, under different restraints
and with different starting conformations were performed
as listed in Table 1. One additional 500 ns long MD run
was performed on the last snapshot of rsrt4 (Run #8)
with all distance restraints removed in order to investi-
gate the stability of the packed conformation of ICL3 in
a restraint-free environment.
The restraint distances that we selected for restraint
MD runs are provided in Table 2. Seven of these distances
are between Asp113 on TM3 and residues on TM5
(Ser203, Ser204, Ser207), TM6 (Phe289, Asn293) and
TM7 (Asn312). One other is between residues on TM6
and TM7. Mainly, the size of the ligand-binding site is
determined by the position of TM5, TM6 and TM7 with
respect to the more stationary TM3 as depicted in Fig. 1.
The distance ranges previously observed for the active
Table 1 Details of several MD runs with and without restraints





1 MD1μsa 1000 No inactive crystal structure,
2RH1
2 MD1μs_cont1 500 No last frame of Run #1
3 MD1μs_cont2 500 No last frame of Run #1
4 rstr1 500 Yes initial frame of Run #1
5 rstr2 500 Yes initial frame of Run #1
6 rstr3 500 Yes frame @ 470th ns of Run #1
7 rstr4 500 Yes frame @ 470th ns of Run #1
8 MD500ns 500 No last frame of Run #7 (rstr4)
9 rstr5 500 Yes last frame of Run #1
aThis run was performed prior to this work in Ozcan’s study [6]. The remaining
runs #2 through #10 were based on the same system created for run #1
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state of the receptor in several different experimental
studies [28–33] are also listed in the second column.
Table 2 also lists the same distances in both active and
inactive x-ray structures (PDB ids: 3SN6 and 2RH1). For
the inactive state, all distances are higher than the ex-
perimentally observed ranges, as expected. Surprisingly,
for the active state, almost all distance values are slightly
out of range. Yet, most of them are smaller than those
in the inactive state, especially those between three
serine residues on TM5 and Asp113 on TM3. Therefore,
we will focus on the first three distances (rows in
Table 2), which clearly distinguish the active states from
the inactive ones.
In the first restrained MD run (rstr1), Ser203-Asp113 dis-
tance was set to 16 Å for the first 300 ns and then increased
to 17 Å for the remaining 200 ns. Other distances were set
to values closer to those observed in the inactive crystal
structure. Here, the value of 17 Å was explicitly selected as
it was recorded in the last frame of the original MD run
(MD1μs), when ICL3 closed upon G-protein binding site.
In the second restrained MD run (rstr2), the same
three critical distances between serine residues and
Asp113 were restrained to 8 Å, 10 Å and 8 Å, which
all fall within the experimental range of the active
state. Similarly, the other distances were set closer to
those in the crystal structures. The third run (rstr3) al-
most share the same set of restraints as in rstr1 and
rstr2, except that it starts with a different initial con-
formation of the receptor (See Table 1). In the fourth
run (rstr4), the same initial conformation was used as
in rstr3, with an additional restraint distance set be-
tween two backbone alpha-carbon atoms in Ser207
and Asp113. Finally, in the last run (rstr5), the final
frame of the original MD run (MD1μs) was used as a
starting conformation and the ligand-binding site was
severely constricted.
Table 2 Restraint distances in all seven MD runs and their corresponding values in experimentally reported active and inactive
states
Distances in crystallographic structures (Å) Bond Restraints (Å)
Residue pair Exper.b (Å) Inactive (PDB id: 2RH1) Active (PDB id: 3SN6) rstr1 rstr2 rstr3 rstr4 rstr5
Ser203Oγa-Asp113Cγa 8.0–10.0 11.2 10.3 17 8 17 17 8
Ser204Oγ-Asp113Cγ 8.0–10.0 14.2 12.4 14 10 14 14 10
Ser207Oγ-Asp113Cγ 8.0–10.0 11.5 10.4 11.7 8 11.7 11.7 8
Ser207Cα-Asp113Cα N/A 12.2 12.0 - - - 17 -
Asn293Cβ1-Asp113Cβ 8.0–10.0 13.6 14.0 14 15 14 14 8
Phe289Cβ-Asp113Cβ 8.0–8.4 11.7 12.3 13 12 13 13 8
Asn312 Cβ-Asp113Cβ 8.0–8.4 9.1 8.6 10 9 10 10 8
Phe289Cβ-Asn312Cβ 8.0–8.4 5.5 5.5 5.5 5.5 5.5 5.5 8
aγ Oxygen, and β and γ Carbon atoms of the side chains were taken into consideration
bThese are the distance ranges observed previously in various experimental studies [28–33]
Fig. 1 Extracellular view of the ligand-binding site. a Only key residues
and the seven restrained distances are highlighted (b) From the same
angle as in (a), the ligand carazolol as bound in the crystal structure of
the inactive state (PDB: 2RH1)
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Results and discussion
Analysis of two continuation runs indicates stability of
packed ICL3
Two 500 ns long MD runs were performed as an extension
of the original MD1μs simulation (Ozcan et al., [6]), as pre-
viously described in Methods section. Initially in MD1μs
run, ICL3 was in an extended conformation, and highly
mobile as illustrated in the upper portion of Fig. 2c (red
ribbon). At around 600 ns of MD1μs, it started to pack
under β2AR and kept its stationary state until the end of
the simulation. The aim here was to investigate how long
this stationary, and relatively restricted state would carry
on. Both extended simulations, the so-called MD1μs_ctd1
and MD1μs_ctd2, selected the final snapshot of the original
run as their initial conformation. MD1μs_ctd1 started with
the same velocities as in MD1μs’s final state, whereas
MD1μs_ctd2 was carried out with a different velocity dis-
tribution, in order to enhance the sampling.
During the first continuation run, ICL3 stayed in its close
form with only minor fluctuations (~2 Å) as shown in the
RMSD profiles illustrated in Fig. 2a. All the RMSD calcula-
tions were carried out after the alignment of each MD
snapshot in the trajectory to the initial snapshot based on
the transmembrane region, as it is the least mobile part
of the receptor. The RMSD profiles labeled as All, Core,
and Tmemb represent the RMSD of the whole receptor,
the core which is the receptor without ICL3 and the
transmembrane region which consists of seven alpha
helices located inside the membrane, respectively (See
Additional file 1: Figure S1). This complete blockage of
the G protein’s binding site suggests an inhibition of
the receptor’s activity.
In the second continuation run using a different vel-
ocity distribution, a temporary increase up to 5 Å in the
RMSD value was observed halfway through the trajec-
tory, which led to a slight opening of ICL3 as reflected
by the white colored snapshot in Fig. 2b. However, this
opening was only temporary and lasted for about 20 ns.
This was followed by a sharp decrease in RMSD to 4 Å
caused by the closure of ICL3 to a position slightly
Fig. 2 Results of original and continuation runs without restraints. RMSD profiles of (a) the first MD1μs_cont1 and (b) the second MD1μs_cont2
continuation runs (500 ns each) shown together with the original 1 μs MD run. c Intracellular view of the initial (red), intermediate (white) and
final (blue) snapshots superimposed for each run. d RMSF profiles for the original, MD1μs_cont1 and MD1μs_ctd2 runs
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different than the initial state. ICL3 stayed there for the
rest of the simulation.
In both continuation runs, the closed state of ICL3 was
preserved, representing an extreme inactive state, where
the G-protein binding site was completely blocked. Ex-
perimental studies revealed both active and inactive states
of the receptor, but none of these structures incorporated
the ICL3 region. Here, it is the presence of ICL3 that
caused the receptor to adopt such a novel inactive state,
which was found to be noticeably stable.
The fluctuation of each residue averaged over the
whole trajectory was determined for each simulation and
illustrated in Fig. 2d. As expected, in both continuation
runs, the mobility of ICL3 stayed at a much lower level
than in the original MD simulation. Moreover, a slight
decrease of mobility was observed in every part of the
receptor, especially on two important loop regions, ICL2
(intracellular) and ECL2 (extracellular), in conjunction
with the decrease in ICL3’s mobility.
The stability of ICL3 was further investigated by a de-
tailed analysis of the hydrogen bond network in the loop
conformation. Figure 3 illustrates the profile of the resi-
dues involved in hydrogen bonding along the trajectory,
which was focused on ICL3 and its neighborhood re-
gion. By the time ICL3 closure is completed at around
600–700 ns, a total of 8 stable hydrogen bonds has been
observed between ICL3 and the rest of the receptor (core
region), which was maintained throughout the simulation.
It is noteworthy that this stable network of hydrogen
bonds was located mostly at the two junctions of ICL3-
TM5 and ICL3-TM6. In the first continuation run,
nearly all 8 hydrogen bonds were preserved, whereas in
the second continuation run, half of them was lost
when a slight opening was observed, but still, an
alternative close state of ICL3 was adopted later to-
wards the end of the simulation with most of the
hydrogen bonds recovered.
In our simulation studies, the closure of ICL3 was
strongly coupled with the lower part of TM6, which ex-
hibited an inward movement of 7.5 Å, in the opposite dir-
ection of the outward movement of 14 Å observed during
activation (experimentally measured at the Cα carbon of
Glu 268 [1]). The RMSD profiles of the intracellular part
of TM6 with respect to the active state (PDB id:3SN6)
illustrated at the top section of Additional file 2: Figure S2
show that as ICL3 started to change its conformation to a
closed state, TM6’s intracellular part shifted to the op-
posite direction of activation and stayed there for both
continuation runs. On the other hand, the intracellular
part of TM5 attached to ICL3 at the other end, seemed
unaffected by these conformational variations. As illus-
trated at the lower section of Additional file 1: Figure S1,
TM5 stabilized at around 2 Å during the original MD as
well as both continuation runs.
Two of the key residues at the binding site are Asp113
on TM3 and Ser207 on TM5, which are known to inter-
act both with agonists and antagonists, via hydrogen
bonds or close contacts. They are situated at the two
distant corners of the binding site and when the ligand
is favorably bound, Ser207 is near the ligand’s aromatic
moiety, while Asp113 usually makes multiple hydrogen
bonds with the ligand’s polar end group (See Fig. 1b).
Therefore, the distance between these two residues
directly controls the binding capability of the ligand.
Experimental measurements already determined an
approximate distance range of [8 Å -10 Å] between the
two side chain atoms, Oγ of Ser207 and Cγ of Asp113,
when the receptor was found in its active state [31, 32].
Fig. 3 Hydrogen bond profiles. The first and the second continuation runs (500 ns each), MD1ms_cont1 and MD1ms_cont2, covering a time
range of [1000:1500] and [1500-2000] ns, respectively. The first 1000 ns corresponds to the original run. Donor and acceptor groups are illustrated
by red and green dots, respectively
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As the receptor passes from an active state to an inactive
one, the same distance also increases and stabilizes
roughly at around 11 Å -12 Å. Thus, as an indicator of ac-
tivation/inactivation, the same distance was monitored for
both continuation runs.
In our original MD run, a close correspondence be-
tween this value and the conformational state of the lower
part of TM6 was established as shown in Fig. 4; as ICL3
exhibited its major conformational shift from an open to a
closely packed state, the lower part of TM6 shifted to-
wards the core of the receptor (See Fig. 4d) and at the
same time, the Ser207-Oγ and Asp113-Cγ distance started
to increase up to 17 Å - 18 Å, which is majorly caused by
the outward shift of TM5 (See Fig. 4c). In both continu-
ation runs, the same distance fluctuated within a range of
13 Å - 18 Å, which is still above 11 Å -12 Å of the crystal
structure of the inactive state [1, 2] (See Fig. 4a and b).
Moreover, no significant conformational change in the
lower part of TM6 was observed, which is mainly caused
by the stationary ICL3.
Rapid closure of ICL3 is observed as restraints expand
the ligand-binding site
The goal here was to investigate the allosteric coupling be-
tween the intra- and extracellular parts of the receptor, by
applying some distance restraints to several key residues at
the extracellular ligand-binding site region (See Fig. 1). As
listed in Table 1 (See Methods section), there exist seven
distances between side chain atoms that were experimen-
tally observed within a certain range when the receptor
adopted an active state [28–33]. In our first constrained
simulation (rstr1), one of those distances which exists
between S203Oγ and D113Cγ, was restrained to 16 Å for
300 ns and later increased to 17 Å for another 200 ns,
while the remaining six were restrained to those observed
in the inactive crystal structure (PDB id: 2RH1) for the
whole 500 ns long simulation (See Table 2).
The high value of 17 Å was especially selected for
S203Oγ-D113Cγ distance in order to reveal the same allo-
steric response of the intracellular part of TM6 and ICL3
observed previously in the original MD run. As expected,
a b
c d
Fig. 4 Simultaneous conformational changes in extracellular and intracellular parts of the receptor. a, b RMSD of intracellular part of TM6 with
respect to active state (PDB id: 3P0G) vs. distance between Ser207-Oγ and Asp113-Cγ in two continuation runs (green dots) together with the
original MD1μs run (red dots). c Extracellular view of the binding site and d side view of TM6 for which the active state, initial and final snapshots
of MD1μs run were colored in green, blue and magenta, respectively
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a close correspondence was observed between the extra-
cellular and intracellular parts of the receptor, as ICL3
packed towards the core of the receptor by the end of
200 ns, which is about 400 ns earlier than in the original
MD1μs.
The closure of ICL3 was monitored through the x
and y coordinates of its center of mass, as illustrated
with colored points corresponding to different time re-
gimes in Fig. 5a. The interacting alpha helical part of G
protein was shown as a straight line connecting all its
x-y coordinates, simply to give an idea about its pos-
ition with respect to ICL3. Also, in Fig. 5b and c, a total
of 20 snapshots gradually changing color from red to
white and finally to blue well demonstrate the closure
of ICL3 towards the core of the receptor during simula-
tion in different angles.
ICL3 preserves its open conformation as restraints narrow
the ligand-binding site
A second restrained MD run (rstr2) was performed
with the same initial frame as used in the first run.
This time, the ligand-binding site region was nar-
rowed down via bond restraints between three serines
(Ser203-Oγ, Ser204-Oγ, Ser207-Oγ) and Asp113-Cγ to
8 Å, 10 Å and 8 Å, respectively. The simulation was
performed for a total of 500 ns. ICL3 preserved its
initially open conformation throughout the simulation,
in agreement with the allosteric coupling behavior
between the intra- and extracellular parts. Similar to
the first restrained run, the position of ICL3’s center
of mass was monitored and all 20 snapshots were il-
lustrated from the side and the intracellular views as
in Fig. 6.
Fig. 5 Results of 500 ns long rstr1 run. a ICL3’s center of mass (x and y only) color-coded by time step. Lines represent the G protein’s α helix x
and y coordinates extracted from the active state’s crystal structure (PDB id: 3SN6). b Side and c intracellular views of 20 snapshots colored from
red (initial), to white (intermediate), to blue (final) during simulation
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ICL3 closure necessitates the outward tilt of TM5
One important finding about the closure of ICL3 in the
first restrained run and also the original run was the sim-
ultaneous outward tilt of TM5 towards the lipid bilayer,
which is crucial in initiating the conformational changes
along TM5 and TM6 and consequently on ICL3 (See
Fig. 4c). In both runs, the distance restraints applied to
residues on TM3 and TM5 shifted TM5 but not the more
stationary TM3. Consequently, this desired outward tilt in
the extracellular part of TM5 was followed by the inward
tilt of the intracellular part of TM5 and also of TM6,
which induced the expected ICL3 closure (See Fig. 4d).
The necessity of TM5’s outward tilt was demonstrated
in another 500 ns long restrained run (rstr3 in Table 2)
that used similar restraints as in the first restrained run,
but an alternative initial conformation, in which ICL3 was
in an extended form but slightly packed and oriented
towards the core of the receptor (See Additional file 3:
Figure S3). The applied restraints simply necessitated an
expanded ligand-binding site, which was expected to in-
duce the closure of ICL3. However, no closure was ob-
served in ICL3, which covered a wide range of alternative
states nearby G-protein binding site and towards the end
of 500 ns, ended up close to its initial position (See Add-
itional file 4: Figure S4). When the conformational change
in TM5 was observed, it was clear that as a result of the
distance restraint, the outward tilt in TM5 was not notable
since both TM3 and TM5 moved apart at the extracellular
side (See Additional file 5: Figure S5). Furthermore, no
major conformational change in the intracellular part of
TM5 was observed. Consequently, ICL3’s motion stayed
random between open and close states, and no closure
was observed. This result shows that the inward tilt of
TM6 at the intracellular side was not enough to induce
Fig. 6 Results of 500 ns long rstr2 run. ICL3 preserves its initial open state as bond restraints narrows the ligand-binding site, in agreement with
the allosteric coupling behavior between the intra- and extracellular parts of the receptor. a ICL3’s center of mass (x and y only) color-coded by
time step. Lines represent the G protein’s a helix x and y coordinates extracted from the active state’s crystal structure (PDB id: 3SN6). b Side and
(c) intracellular views of 20 snapshots colored from red (initial), to white (intermediate), to blue (final) during simulation
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the closure of ICL3, which necessitates the inward tilt in
both TM5 and TM6.
Our next attempt in rstr4 was to impose an additional
bond restraint that will bring out the desired outward tilt in
TM5, which was not obvious in our previous run (See
Table 2). Since the backbone atoms’ fluctuations are usually
minor compared to those of side chain atoms, the bond re-
straint of 17 Å was imposed between two backbone atoms,
Cα atom of Ser207 and Cα atom Asp113. This time, the new
additional restraint was expected to cause the important out-
ward tilt in the extracellular part of TM5. Indeed, both the
expected ICL3 closure and the desired outward tilt in TM5
were observed. In addition, ICL3 closure was accomplished
under 100 ns, which was two times faster than the first re-
strained run (See Fig. 7). Another difference was the final
position of ICL3, which was shifted about 5 Å in the x-axis
with respect to the previously observed positions and located
towards the middle of the G-protein binding cavity. In order
to further investigate the stability of ICL3 in this alternative
closed state, another 500 ns long MD run (MD500ns) was
performed with all restraints removed (run #8 in Table).
ICL3 preserved its closed state as illustrated with the center
of mass profile in Additional file 6: Figure S6.
Packed ICL3 could not be opened by constricting the
ligand-binding site
The final restrained run (rstr5) was set up to observe the
allosteric effect caused by narrowing the ligand-binding
site region. The final snapshot of the original MD run
(MD1μs) was taken as the initial conformation. Here,
the ICL3 was fully packed, blocking the G-protein bind-
ing site. The ligand-binding site was severely constricted
Fig. 7 Results of 500 ns long rstr4 run. The expected ICL3 closure was observed under 100 ns, when an additional bond restraint was imposed
between the backbone atoms in the ligand-binding site. a ICL3’s center of mass (x and y only) color-coded by time step. Lines represent the G
protein’s a helix x and y coordinates extracted from the active state’s crystal structure (PDB id: 3SN6). b Side and (c) intracellular views of 20
snapshots colored from red (initial), to white (intermediate), to blue (final) during simulation
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with distance values of 8 Å between almost all pairs of
atoms (See Table 2), yet any attempt failed to free the
ICL3, which only covered a very confined space during
500 ns long MD run (See Fig. 8). This last result simply
point to an important aspect of the receptor’s dynamics.
It is rather easy to induce the packing of a loose ICL3 by
expanding the extracellular binding site region. Yet, it is
almost impossible to unpack an already packed or a half
packed ICL3 by simply narrowing the extracellular bind-
ing site region. Clearly, the energetic barrier to unpack
the ICL3 and consequently open the G-protein binding
site is too high to be overcome by a few restraints ap-
plied at a far region of the receptor. This energetic bar-
rier is most likely due the existence of several hydrogen
bonds that exist between ICL3 and the adjacent ends of
TM5 and TM6. Thus, the outward tilt of TM6 including
the ICL3, which exposes the G-protein binding site,
needs to be induced by some exterior forces acting dir-
ectly on that specific region only.
One activation mechanism proposed by Dror et al. [34]
also supports this finding. They have shown that in its basal
form, the receptor’s intracellular part of TM6 fluctuated be-
tween open or half open (intermediate) states, and adopted
a fully open active state only when a G protein was bound
from the intracellular region and pushed the binding site to
an open form. If an agonist was bound at the extracellular
binding site, then this active state was stabilized. On the
other hand, when G protein was released from this agonist-
bound state, it was observed that the receptor’s intracellular
part of TM6 quickly returned to its inactive state obstruct-
ing the G-protein binding site. This finding indicated that
the active state cannot be induced by some agonists alone
and can only be reached by some exterior forces.
Conclusions
The very inactive state of the receptor [6], was further
investigated by two 500 ns long MD runs, which pre-
sented a highly stable packed state of ICL3. Although a
slight tendency for its opening was observed in one of
these simulations (Fig. 2), the closed state was adopted
shortly afterwards. The hydrogen bond network analysis
revealed several hydrogen bonds connecting ICL3 with
adjacent TM5 and TM6 regions, thus stabilizing this
novel packed state.
Several distance restraints were applied to key residues at
the extracellular ligand-binding site in order to investigate
their effect on the intracellular G-protein binding site in-
cluding ICL3. Bond restraints caused either an expansion
or constriction of the ligand-binding site. Key distances that
majorly control the size of the cavity were between Asp113
on TM3 and three serine residues (S203, S204 and S207)
on TM5. When the ligand-binding site was forced to an
expanded/open state via these restraints (rstr1), ICL3 clos-
ure took place following a straight pathway towards the G-
protein binding site, as in the original MD1μs run. On the
other hand, when the same ligand-binding site was forced
to a constricted state (rstr2), no change at the intracellular
part was observed as ICL3 preserved its initial open con-
formation. These two observations were both in agreement
with the ‘pincer-like’ behavior of the receptor, where the
intracellular part becomes wider as the extracellular part
becomes narrower, and vice versa [35].
In both runs MD1μs and rstr1, closure of ICL3 was ob-
served to closely couple with the inward tilt of both TM5’s
and TM6’s intracellular parts and also the outward tilt in
TM5’s extracellular part, where the signal propagation
starts. In our third restrained run (rstr3) which started
Fig. 8 Results of the fifth restrained rstr5 run. Here, the bond restraints narrowed the ligand-binding site region while ICL3 was completely
packed. The initially packed/closed state of ICL3 was preserved throughout 500 ns long simulation. a The initial (red) and final (blue) snapshots of
MD run, (b) ICL3’s center of mass (x and y only) color-coded by time step, where lines represent the G protein’s a helix x and y coordinates
extracted from the active state’s crystal structure (PDB id: 3SN6)
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with an alternative state of the receptor, directed closure
of ICL3 was not observed. When initial and final snap-
shots were aligned, it was clear that the distance restraints
forced TM3 rather than TM5 to be displaced and conse-
quently, only a minor outward tilt in TM5’s upper half
was observed with no significant displacement at its intra-
cellular region. Addition of an extra restraint between
backbone atoms of the same residue pair (S203-D113)
produced the desired outward tilt of TM5 at the upper
half in rstr4 run. Consequently both TM5 and TM6 were
displaced at the intracellular part and ICL3 closed instant-
aneously on G-protein binding site within 100 ns, which
was the most rapid closure to be observed so far. Here,
ICL3 adopted an alternative packed state, which was fur-
ther observed to be stable for another 500 ns when the re-
straints were removed.
Another set of restraints that constrict the ligand-
binding site was applied on the closed ICL3 state (rstr5) in
order to free the loop from its interactions with the recep-
tor. However, our attempt to open up ICL3 failed during
the time scale of our runs. To summarize, our current
study revealed alternative packed states of ICL3, which are
stabilized by several hydrogen bonds between ICL3 and
the rest of the receptor. Furthermore, in contrast to the
persistence of ICL3 in its locked position, it was almost al-
ways straightforward to bring ICL3 from a loose, free state
to a locked one by simply applying a few distance
restraints that expand the extracellular ligand-binding site.
Starting with such very inactive states, the receptor
stayed almost irreversibly inhibited during our runs, which
in turn decreased the overall mobility of the receptor.
Experimental support is currently lacking for the locked,
inactive state of β2AR, due to the fact that ICL3 has been
missing in most studies including the crystal structures.
The bond restraints imposed in our study simply rep-
resent the restrictions caused by ligands of various sizes
bound at the ligand-binding site. Small agonist mole-
cules tend to fit to a narrow region, whereas the antago-
nists and inverse agonists of larger size induce a more
expanded binding site. As a result of allosteric coupling
between intra- and extracellular regions, which is medi-
ated through the transmembrane helices, particularly
TM5 and TM6, the population of conformational states
of ICL3 between unpacked and packed positions and
thereby the binding of G-protein were modulated.
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